Viral Gastroenteritis Market Size, Share, By Type (Rotavirus and Norovirus), By Drugs (Antacids, Antibiotics, Laxatives and Antimobility Agents), By Diagnosis, (Rapid Stool Test and Physical Examination), By End-Use (Hospital, Diagnostic Centers, Clinics and Others), and By Region (North America, Europe, Asia Pacific, Latin America, And Middle East & Africa) - Market Trends, Analysis, And Forecast Till 2034

Report Code: PMI469421 | Publish Date: March 2024 | No. of Pages: 170

Global Viral Gastroenteritis Market Companies

  • Valeant Pharmaceuticals International Inc.
  • Janssen Global Services
  • LLC
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline Plc.
  • Bayer AG
  • AstraZeneca
  • Sanofi

Recent News:

  • Using the highly effective rotavirus vaccinations as a foundation, researchers at Washington University School of Medicine in St. Louis developed a revolutionary strategy in April 2023 to develop a vaccine against norovirus. Rotavirus is a separate type of virus that also causes diarrhea. By combining the two main viruses that cause diarrhoea, the innovative dual vaccination creates antibodies that guard against illnesses from both rotavirus and norovirus.